赵一虹, 高军茂, 何合良. 小靶区调强放疗及化疗对鼻咽癌的远期疗效评价[J]. 实用临床医药杂志, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020
引用本文: 赵一虹, 高军茂, 何合良. 小靶区调强放疗及化疗对鼻咽癌的远期疗效评价[J]. 实用临床医药杂志, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020
ZHAO Yihong, GAO Junmao, HE Heliang. Long-term efficacy of small target region intensity-modulated radiotherapy and chemotherapy in treatment of patients with nasopharyngeal cancer[J]. Journal of Clinical Medicine in Practice, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020
Citation: ZHAO Yihong, GAO Junmao, HE Heliang. Long-term efficacy of small target region intensity-modulated radiotherapy and chemotherapy in treatment of patients with nasopharyngeal cancer[J]. Journal of Clinical Medicine in Practice, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020

小靶区调强放疗及化疗对鼻咽癌的远期疗效评价

Long-term efficacy of small target region intensity-modulated radiotherapy and chemotherapy in treatment of patients with nasopharyngeal cancer

  • 摘要: 目的 探讨小靶区调强放疗及化疗治疗鼻咽癌的长期疗效.方法 回顾性分析372例鼻咽癌患者的临床资料,所有患者均采取缩小临床靶区调强放疗及化疗,并对所有患者进行5年的随访.结果 本组患者的5年总生存率、局部控制率、无区域复发生存率、无远处转移生存率及无局部淋巴结复发率分别为82.80%、95.16%、97.31%、86.02%及96.24%.多因素分析表明,年龄、T分期、N分期是制约生存的预后因素,T分期、N分期是无远处转移的预后因素.进展期鼻咽癌患者中,诱导化疗组的5年生存率高于无诱导化疗组(P>0.05),辅助化疗者5年无远处转移生存率明显低于无辅助化疗者(P<0.01).结论 小靶区调强放疗及化疗治疗鼻咽癌的效果好.

     

/

返回文章
返回